FGF2 and osteoporosis: The in vitro and in vivo findings from the present study demonstrated the disruption of bone repair in osteoporosis while also revealing that FGF-2 still promotes novel bone formation, albeit with attenuated yet substantial efficacy compared to non-osteoporotic states.